Escalon Medical (ESMC) Annual Cash Flow Statement

Annual · GAAP · USD millions
Access ESMC quarterly Cash Flow →
The table below presents a historical view of Escalon Medical's cash flow activity, supporting analysis of liquidity trends over time.
Annual Report, GAAP in USD millions
ITEM
(Jun 30 2025)
12 Months
(Jun 30 2024) (Jun 30 2023) (Jun 30 2022) (Jun 30 2021)
Operating Activities
Income0.19
Depreciation & amortization0.04
Amortization of Other Assets0.00
Increase (Decrease) in Deferred Revenue0.05
Impairment of Intangible Assets, Indefinite-lived (Excluding Goodwill)0.00
Provision For Loan Losses Expensed-0.01
Increase (Decrease) in Inventories0.49
R & D, Environmental and Other Expense0.00
Gain (Loss) on Disposition of Property Plant Equipment, Excluding Oil and Gas Property and Timber Property0.00
Share-based Compensation0.00
Income (Loss) from Equity Method Investments0.00
Financial Instruments and Foreign Currency Transaction0.00
Notes Assumed-
Provision For Valuation Allowance-
Related Party Transaction Due From To Related Party-
Other Nonoperating Income-
Increasedecreaseinliabilitiesofdiscontinuedoperations0.00
Financing Receivable Allowance For Credit Losses Recovery-
Other Nonoperating Income Expense-0.34
Impairment Of Intangible Assets Excluding Goodwill-
Us Gaap_ Other Nonoperating Income Expensenoncash-
Income taxes-0.32
Losses/ -gains on Investments net0.00
Increase (Decrease) in Accounts Receivable-0.63
Increase (Decrease) in Accounts Payable0.03
Increase (Decrease) in Accrued Liabilities0.05
Deferred Revenue and Customer Advances and Deposits0.00
Prepaid Expense and Other Assets0.00
Other Working Capital-0.02
Other Noncash Income (Expense)0.00
Other net0.00
Payments for (Proceeds from) Other Operating Activities0.00
Discontinued operations0.00
Net Cash flow from Operating Activities0.38
Investing Activities
Capital Expenditures0.00
Sale of Capital Items0.00
Short-term Investments Proceeds0.00
Short-term Investments Acq.0.00
Payments for Leasing Costs0.00
P A Y M N E T T O A C Q U I R E A S S E T S D I S C O N T I N U E D O P E R A T I O N S-
Restricted Cash and Investments Increase (Decrease)0.00
Payments for (Proceeds from) Loans0.00
Payments for (Proceeds from) Deposits0.00
Payments for (Proceeds from) Other Investments0.00
Payments for (Proceeds from) Federal Reserve and FHLB0.00
Acquisition Net of Cash Acquired0.00
Payments to Acquire Interest in Subsidiaries and Affiliates0.00
Sale of businesses0.00
Accounts payable0.00
Receivables0.00
Payments for (Proceeds from) Other Investing Activities0.00
Other Net0.00
Discontinued operations0.00
Net Cash Flow from Investing Activities0.00
Financing Activities
Short-term debt Net0.00
Other borrowing transactions0.00
Long-term debt - borrowings0.00
Long-term debt - repayments-0.04
Federal Home Loan Bank and Federal Funds0.00
Issuances / -repurchases of Comm. Stock0.00
Partnership and Parent Transactions0.00
Issuances / -repurchases of Pref. Stock0.00
Deposits, Annuities, Contract Holders Funds0.00
Other financing activities net0.00
Other net0.00
Restricted Cash And Cash Equivalents-
Restricted Cash0.26
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents1.08
Repayment Of E I D L Loan-
Payments of Dividends, Preferred Stock and Preference Stock0.00
Dividends paid0.00
Net Cash Flow from Financing Activities-0.04
Effect of exchange rate on cash flow0.00
Discontinued operations0.00
Free Cash Flow0.38
Total Cash Flow0.34
4 historic quarters locked

Sign in to unlock the full Escalon Medical cash flow history.

About Escalon Medical Corp Annual Cash Flow Statement

What this statement shows

This page presents issuer-reported cash flow data, including operating, investing, financing, net, and free cash flow, as disclosed in SEC 10-K filings and normalized by CSIMarket.

Source & verification

  • Form: 10-K (Period: 20250630)
  • Filed with the SEC: September 29, 2025
  • Source: esmc-20250630.htm

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - normalization in the CSIMarket.com database.
  • Accession: 0001628280-25-043095

Figures are derived from filed reports and may be restated. Historical data is subject to revision.

Untitled Document





                    
Get the full CSIMarket dataset: Subscribe API License